N/A

Marco Fazzari is an Assistant Professor (tenure track) in the Department of Pharmacology and Chemical Biology at the University of Pittsburgh School of Medicine. He received his BS/MS in Pharmaceutical Chemistry and Technology Sciences and his Ph.D. in Mediterranean Fruit Culture from the University of Palermo, Italy. In addition, he was a postdoctoral researcher at the Università degli Studi di Palermo. Marco Fazzari has a broad background in pharmacology and biochemistry, with specific expertise and training in drug discovery and mass spectrometry. His research is focused on studying the generation, pharmacokinetics, and signaling actions of electrophilic lipid signaling mediators to develop a pharmacological strategy for the treatment of cardiovascular diseases (CVD) and Parkinson’s disease (PD).

Robert H. Newman is a Nathan F. Simms Distinguished Professor in the Department of Biology at North Carolina A&T State University. He earned his Bachelor’s degree in Biology and Biochemistry from the McDaniel College and his Ph.D. in Biochemistry and Molecular Biology from the Johns Hopkins University Bloomberg School of Public Health. He then conducted his postdoctoral research in the Department of Pharmacology and Molecular Sciences in the Johns Hopkins University School of Medicine before joining the faculty at NC A&T. Research in his laboratory is focused on understanding the organization and regulation of phosphorylation-dependent signaling networks in health and disease. Research is organized around two central questions: (1) which cellular proteins are phosphorylated by a given kinase and (2) how are specific kinases and phosphatases—and ultimately the signaling networks of which they are part—regulated within the cellular environment.